Solas Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$10.4M |
| 2 |
AdvanSix
ASIX
|
+$10.2M |
| 3 |
Bristow Group
VTOL
|
+$7.54M |
| 4 |
Goodyear
GT
|
+$7.47M |
| 5 |
ZIMV
ZimVie
ZIMV
|
+$3.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Par Pacific Holdings
PARR
|
+$9.89M |
| 2 |
Petco
WOOF
|
+$9.15M |
| 3 |
Ardagh Metal Packaging
AMBP
|
+$9.1M |
| 4 |
SNWV
SANUWAVE Health Inc
SNWV
|
+$8.68M |
| 5 |
Citi Trends
CTRN
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.45% |
| 2 | Energy | 19.87% |
| 3 | Materials | 14.77% |
| 4 | Consumer Discretionary | 12.41% |
| 5 | Consumer Staples | 6.81% |
Similar funds
Solas Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Solas Capital Management held 26 positions worth $179M, up 0.54% from $178M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Solas Capital Management withdrew a net $9.84M in Q2 2025, closing 6 positions and reducing 13 holdings. Its most notable exit was Par Pacific Holdings, an estimated $9.89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 40% a quarter earlier, followed by Energy and Materials.
Against the trend, Solas Capital Management opened a new position in Regeneron Pharmaceuticals worth $9.76M.
- Solas Capital Management's largest Q2 2025 buy was Regeneron Pharmaceuticals: 18,594 shares worth $9.76M.
- Solas Capital Management added most to ZimVie in Q2 2025, an estimated $3.16M increase.
- Solas Capital Management's biggest Q2 2025 reduction was SANUWAVE Health Inc, cutting an estimated $8.68M.
- Solas Capital Management fully exited Par Pacific Holdings in Q2 2025, selling an estimated $9.89M.
- Solas Capital Management's ten largest holdings make up 74% of its $179M portfolio in Q2 2025.
- Solas Capital Management opened 5 new positions and closed 6 in Q2 2025.
- Solas Capital Management's portfolio value rose 0.54% quarter-over-quarter to $179M.
Based on Solas Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.